FOXO TECHNOLOGIES INC. Operating Income
FOXO TECHNOLOGIES INC. (FOXO) reported Operating Income of $8.75 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-14
- FOXO TECHNOLOGIES INC. operating income (loss) for the quarter ending 2026-06-30 was $8.75M, a 1442.61% increase year-over-year.
- FOXO TECHNOLOGIES INC. operating income (loss) for the quarter ending 2026-03-31 was -$276.85K.
- FOXO TECHNOLOGIES INC. operating income (loss) for the quarter ending 2025-12-31 was -$8.49M.
- FOXO TECHNOLOGIES INC. operating income (loss) for the quarter ending 2025-09-30 was -$859.82K.
- FOXO TECHNOLOGIES INC. operating income (loss) for fiscal 2025 was -$10.33M.
- FOXO TECHNOLOGIES INC. operating income (loss) for fiscal 2024 was -$7.76M.
- FOXO TECHNOLOGIES INC. operating income (loss) for fiscal 2023 was -$22.19M.
- FOXO TECHNOLOGIES INC. operating income (loss) for fiscal 2022 was -$40.17M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 6 month as first filed | Operating Income (Loss) 8 month | Operating Income (Loss) 8 month as first filed | Operating Income (Loss) 9 month | Operating Income (Loss) 9 month as first filed | Operating Income (Loss) 12 month | Operating Income (Loss) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $8.75M 10-Q · filed 2026-08-14 | $8.47M 10-Q · filed 2026-08-14 | -$17.94K derived: sum of 3 quarters · filed 2026-08-14 | -$877.76K derived: sum of 4 quarters · filed 2026-08-14 | ||||||
| 2026-03-31 | -$276.85K 10-Q · filed 2026-05-15 | -$8.77M derived: sum of 2 quarters · filed 2026-05-15 | -$9.63M derived: sum of 3 quarters · filed 2026-05-15 | -$9.06M derived: sum of 4 quarters · filed 2026-08-14 | ||||||
| 2025-12-31 | -$8.49M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | -$9.35M derived: sum of 2 quarters · filed 2026-04-15 | -$8.78M derived: sum of 3 quarters · filed 2026-08-14 | -$10.33M 10-K · filed 2026-04-15 | ||||||
| 2025-09-30 | -$859.82K 10-Q · filed 2025-11-10 | -$292.70K derived: sum of 2 quarters · filed 2026-08-14 | -$1.84M 10-Q · filed 2025-11-10 | -$5.83M derived: sum of 4 quarters · filed 2026-08-14 | ||||||
| 2025-06-30 | $567.12K 10-Q · filed 2026-08-14 | -$979.86K 10-Q · filed 2026-08-14 | -$4.97M derived: sum of 3 quarters · filed 2026-08-14 | -$5.97M derived: sum of 4 quarters · filed 2026-08-14 | ||||||
| 2025-03-31 | -$1.55M 10-Q · filed 2026-05-15 | -$5.54M derived: sum of 2 quarters · filed 2026-05-15 | -$6.54M derived: sum of 3 quarters · filed 2026-05-15 | -$8.13M derived: sum of 4 quarters · filed 2026-05-15 | ||||||
| 2024-12-31 | -$3.99M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | -$4.99M derived: sum of 2 quarters · filed 2026-04-15 | -$6.58M derived: sum of 3 quarters · filed 2026-04-15 | -$7.76M 10-K · filed 2026-04-15 | ||||||
| 2024-09-30 | -$1.01M 10-Q · filed 2025-11-10 | -$1.00M 10-Q · filed 2024-11-19 | -$2.59M derived: sum of 2 quarters · filed 2025-11-10 | -$3.77M 10-Q · filed 2025-11-10 | -$3.77M 10-Q · filed 2024-11-19 | -$7.46M derived: sum of 4 quarters · filed 2025-11-10 | ||||
| 2024-06-30 | -$1.59M 10-Q · filed 2025-08-19 | -$1.59M 10-Q · filed 2024-08-19 | -$2.77M 10-Q · filed 2025-08-19 | -$2.77M 10-Q · filed 2024-08-19 | -$6.45M derived: sum of 3 quarters · filed 2025-08-19 | -$9.96M derived: sum of 4 quarters · filed 2025-08-19 | ||||
| 2024-03-31 | -$1.18M 10-Q/A · filed 2025-08-19 | -$1.18M 10-Q · filed 2024-06-28 | -$4.86M derived: sum of 2 quarters · filed 2025-08-19 | -$8.37M derived: sum of 3 quarters · filed 2025-08-19 | -$15.97M derived: sum of 4 quarters · filed 2025-08-19 | |||||
| 2023-12-31 | -$3.68M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | -$7.19M derived: sum of 2 quarters · filed 2025-04-15 | -$14.80M derived: sum of 3 quarters · filed 2025-04-15 | -$22.19M 10-K · filed 2025-04-15 | -$22.19M 10-K · filed 2024-06-06 | |||||
| 2023-09-30 | -$3.51M 10-Q · filed 2024-11-19 | -$11.11M derived: sum of 2 quarters · filed 2024-11-19 | -$18.50M 10-Q · filed 2024-11-19 | -$39.37M derived: sum of 4 quarters · filed 2024-11-19 | ||||||
| 2023-06-30 | -$7.61M 10-Q · filed 2024-08-19 | -$15.00M 10-Q · filed 2024-08-19 | -$35.86M derived: sum of 3 quarters · filed 2024-08-19 | -$44.67M derived: sum of 4 quarters · filed 2024-08-19 | ||||||
| 2023-03-31 | -$7.39M 10-Q · filed 2024-06-28 | -$28.25M derived: sum of 2 quarters · filed 2024-06-28 | -$37.07M derived: sum of 3 quarters · filed 2024-06-28 | -$43.00M derived: sum of 4 quarters · filed 2024-06-28 | ||||||
| 2022-12-31 | -$20.86M derived: 10-K 12 month − 10-Q/A 9 month · filed 2024-06-06 | -$29.67M derived: sum of 2 quarters · filed 2024-06-06 | -$35.60M derived: sum of 3 quarters · filed 2024-06-06 | -$40.17M 10-K · filed 2024-06-06 | ||||||
| 2022-09-30 | -$8.81M 10-Q/A · filed 2024-06-04 | -$14.74M derived: sum of 2 quarters · filed 2024-06-04 | -$19.31M 10-Q/A · filed 2024-06-04 | -$20.61M derived: sum of 4 quarters · filed 2024-06-04 | ||||||
| 2022-06-30 | -$5.93M 10-Q · filed 2023-08-10 | -$1.17M 10-Q · filed 2022-08-12 | -$10.49M 10-Q · filed 2023-08-10 | -$3.57M 10-Q · filed 2022-08-12 | -$11.80M derived: sum of 3 quarters · filed 2023-08-10 | -$16.15M derived: sum of 4 quarters · filed 2023-08-10 | ||||
| 2022-03-31 | -$4.56M 10-Q · filed 2023-05-11 | -$2.40M 10-Q · filed 2022-05-16 | -$5.87M derived: sum of 2 quarters · filed 2023-05-11 | -$10.22M derived: sum of 3 quarters · filed 2023-05-11 | -$10.42M derived: sum of 4 quarters · filed 2023-05-11 | |||||
| 2021-12-31 | -$1.30M 10-K · filed 2022-03-07 | -$5.66M derived: sum of 2 quarters · filed 2022-11-21 | -$5.86M derived: sum of 3 quarters · filed 2022-11-21 | -$15.03M 10-K · filed 2023-03-31 | ||||||
| 2021-09-30 | -$4.36M 10-Q · filed 2022-11-21 | -$362.06K 10-Q · filed 2021-11-15 | -$4.56M derived: sum of 2 quarters · filed 2022-11-21 | -$11.87M 10-Q · filed 2022-11-21 | -$778.79K 10-Q · filed 2021-11-15 | -$5.92M derived: sum of 4 quarters · filed 2022-11-21 | ||||
| 2021-06-30 | -$203.12K 10-Q · filed 2022-08-12 | -$416.73K 10-Q · filed 2022-08-12 | -$1.57M derived: sum of 3 quarters · filed 2022-08-12 | |||||||
| 2021-03-31 | -$213.61K 10-Q · filed 2022-05-16 | -$1.37M derived: sum of 2 quarters · filed 2022-05-16 | ||||||||
| 2020-12-31 | -$1.15M 10-K · filed 2022-03-07 | -$1.15M 10-K/A · filed 2021-05-17 | -$38.25K 10-K · filed 2021-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |